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Abstract
Chronic abacterial prostatitis or chronic pelvic pain syndrome remains an urgent problem due to its high prevalence among
young men of reproductive age. Chronic abacterial prostatitis or chronic pelvic pain syndrome, especially its etiology,
diagnosis and treatment, is the most discussible issue in the literature and among healthcare professionals. Many modern
authors increasingly associate the etiology of this disease with viruses. However, viral etiology of chronic abacterial prostatitis
has not been clearly confirmed yet.
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Nowadays, chronic prostatitis remains rather widespread,
insufficiently studied and poorly treated condition. It ranks
first among inflammatory diseases of the male genitalia and
male diseases in general [6, 41]. Chronic prostatitis is called a
”basket for clinically unclear conditions”. Probably, therefore,
this disease develops in about 1 in 10 urological patients in
Ukraine [3, 4, 5, 6]. According to various authors, the preva-
lence of chronic prostatitis is 4.5 - 9%, and the frequency
of seeking medical assistance in outpatient practice reaches
35-41% [1, 3, 4]. ”Prostatic syndrome” or its newer syn-
onym ”chronic pelvic pain syndrome” (CPPS) is a condition
in which an infectious agent can not be detected; it is con-
sidered as multifactorial pathology [1]. Prostatitis affects
mainly young and middle-aged men, i.e. the most sexually
active ones, and is often complicated copulatory and repro-
ductive dysfunction [2]. Recently, prostatitis with co-existent
benign prostatic hyperplasia has been diagnosed in older men
as well [29]. There is an evidence that patients with chronic
prostatitis develop secondary immunodeficiency [3]. Nowa-
days, many urologists associate the increase in the number of
patients suffering from chronic prostatitis not only with the
greater number of sexually transmitted infections, changes in
sexual behavior, urbanization and other social, demographic
and medical factors, but also with the emergence of more
advanced diagnostic methods [30]. However, the diagnostics
of chronic prostatitis may be difficult, since in most cases,
even significant morphological changes in the prostate can
occur without clinical symptoms. Thus, B. D. Bennet et al.
who pathoanatomically studied 150 corpses of men who had
no complaints of prostatitis during their lives and died at the
age of 16-42 years, revealed inflammatory infiltration in the
glandular epithelium of the prostate in 110 cases (73%) [31].
K. Boston conducted similar study and revealed morphologi-
cal changes typical for chronic prostatitis in the prostate of 80
out of 100 male corpses [30, 31].
The study of prostatitis has a long history. Herophylus
first described the prostate gland as an organ in about 350
BC, and in 1815, Legneau published his observations on the
inflammatory process in the prostate. Belfield was the first
to isolate prostatitis as a separate nosological unit in 1800.
At the present stage, to make a diagnosis of chronic prostati-
tis, a complete physical examination of men is required [31].
According to the theory proposed by G. Battalias (2000), pro-
statitis results from the disorder of urine passage, the condition
which, in a number of cases, is aggravated by microorganism
involvement. In chronic prostatitis, as well as in prostatodynia,
pain is caused by urethral hypertension. Urethral sensitivity
as well as tenderness or discomfort is the reflection of this
hypertension. High maximal urethral pressure results from
increased adrenergic stimulation, which, in turn, is due to
local or general factors. All this causes the reflux of urethral
content into the peripheral zone of the prostate gland and leads
to chronic abacterial or bacterial (in case of infectious agent
involvement) prostatitis [28]. Recently, global decline in male
reproductive capacity has been noticed. In half of infertile
marriages, prostate pathology is known to be the major cause
[4]. Therefore, the problem of increasing the effectiveness
of diagnosis and treatment of chronic prostatitis is of both
medical and social significance. Today, chronic prostatitis
ranks first among prostate diseases as an independent disease
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(59%) or a disease co-existing with benign prostatic hyperpla-
sia (85% of cases) [5]. At present, only in 5-10% of cases,
chronic prostatis has a bacterial nature, in about 60-65% of
cases, abacterial prostatis is found and in 30 - 35% of cases,
prostatodynia is observed [6, 7, 8]. K. Nickel’s classification
being one of the major classifications adopted in Europe, dis-
tinguishes bacterial prostatitis (acute and chronic), chronic
abacterial prostatitis (CAP), prostatodynia or CPPS [9]. All
disadvantages of the traditional classification system gave
grounds to develop and validate the classification system of
chronic prostatitis by the National Institutes of Health (NIH)
of the United States in December 1995.
Category I (acute bacterial prostatitis) and category II
(chronic bacterial prostatitis) correspond to the traditional
division into acute and chronic bacterial prostatitis. The ad-
dition of new categories, namely CPPS of inflammatory and
noninflammatory prostatitis (category III) and asymptomatic
inflammatory prostatitis (category IV) was aimed at solving
problems and eliminating drawbacks of the traditional clas-
sification. Treatment of patients with category I or category
II chronic prostatitis is described in detail in most manuals
on inflammatory diseases of male genital organs. However,
there are considerable difficulties when selecting medications
for treating patients with CAP - category IIIA and category
IIIB according to the NIH classification. This is due to the
uncertainty of CAP definition, unclear etiology and patho-
genesis of this disease. This pertains mostly to category IIIB
(CAP/CPPS) [10]. Causes of CAP/CPPS are not fully iden-
tified. Currently, CAP/CPPS is considered as multifactorial
disease associated with both non-infectious factors (inflamma-
tion, autoimmune processes, hormonal imbalance, hypertonia
of pelvic floor muscles accompanied by myalgia, etc.) and
agents undetectable by traditional methods: C. Trachoma-
tis, M. Hominis, U. urealyticum, M. genitalium, T. vaginalis
[11]. According to the literature data, the development of
chronic prostatitis is necessarily preceded by hemodynamic
disorder. Hyperemia or stasis in the prostate gland contributes
to the development of inflammation being the cause of chronic
prostatitis exacerbation [32, 33]. If clear picture concerning
the etiology and pathogenesis of CPPS is absent, treatment
of patients with this pathology has an empirical nature. Re-
peated and often ineffective treatment courses undergone by
such patients reduce their capability to work, which also leads
to economic losses [12]. In addition, therapeutic measures
are traditionally aimed at eliminating or reducing the inten-
sity of pain, improving urination and psycho-emotional state,
and do not involve the management of co-existent disorders.
Treatment of chronic prostatitis depends on the severity of
the disease, its duration, co-occurrence of sexual dysfunction.
However, the effectiveness of treatment is low. It is very dif-
ficult to restore the function of the prostate. Young patients
diagnosed with chronic prostatitis may develop erectile dys-
function, their reproductive function may be disturbed as well
[12]. Recent researches have proved the effect of both sys-
temic and local immune mechanisms on the development of
chronic prostatitis. A significant role in the development of
inflammatory reactions in patients with CPPS is played by
cytokines, which are produced as a result of impaired immune
response. Patients of this category have elevated levels of
proinflammatory cytokines such as IL-1, IL-1b, IL-6, IL-8,
TNF-a in their spermatic plasma, which indicate the inflam-
matory process in the prostate and spermatic ducts [25].
At the present stage, the etiology of CAP is more often
associated with viruses. For the first time, the assumption con-
cerning the presence of herpes simplex and cytomegalovirus
in male ejaculate was published in the late 1970s [42]. The
uncontrolled widespread increase in the incidence of geni-
tal herpes (GH) equates the problem of herpesvirus infec-
tion (HVI) with the most urgent socially significant health
problems. HVI, particularly herpes infection (HI) and cy-
tomegalovirus infection (CMVI) are common, and their in-
cidence tends to increase annually in many countries of the
world [14, 15, 16]. About 90% of the adult population are
infected and have antibodies to several types of herpesviruses
[17, 18, 19]. The reactivation of latent herpes virus occurs
on the background of stress and endocrine disorders, in pa-
tients with primary and secondary immunodeficiency, as well
as in those undergoing immunosuppressive therapy (after or-
gan transplantation). Polytropism of herpes viruses causes a
variety of clinical manifestations that come into the view of
different specialists, e.g. dermatovenereologists, gynecolo-
gists, urologists, neurologists, ophthalmologists and dentists
[20, 21]. The incidence of GH in Western Europe exceeds
80 cases per 100, 000 people. According to Halioua B, et
al. (1999), 86 million people all over the world are infected
with herpes simplex virus (HSV) type 2, which is traditionally
associated with GH, although, it has been proved that GH can
be caused by HSV type 1 [43]. HI is one of the most common
human viral infections: 90% of adults develop antibodies to
HSV-I in their serum and 73% - to HSV-II, which more often
causes GH [23, 43]. According to various authors, prostatitis
is caused or maintained by HSV in 29-30% of cases. Chronic
prostatitis with herpetic urethritis manifests itself mostly in
the catarrhal form, while its clinical course is characterized by
frequent and persistently recurrent nature [3]. The effect of
herpesvirus on the male reproductive system has been proved
[22, 23]. The presence of herpesvirus markers in organs and
tissues of the male reproductive system, as well as the data
indicating an increased incidence of HSV manifestations in
men’s ejaculate, indicate the possible role of HVI as the eti-
ology of chronic infection of the male reproductive system
[22, 23]. There are insufficient data indicating the influence of
CMVI on the male genital system, the reproductive system in
particular, and they are quite contradictory. The effect of hu-
man HSV-I and HSV-II and CMV on the course of pregnancy
in women has been proven [24].
CMVI is one of the most common diseases in the world.
It is a sexually transmitted infection that is transferred through
saliva, maternal milk, during pregnancy, from mother to her
child. HSV and CMV are widespread among people, they can
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be transmitted through sexual intercourse and cause a wide
range of diseases: GH, viral and bacterial epididymitis, male
infertility or erectile dysfunction [26].
At present, the problem of CAP is extremely relevant.
There are many research works concerning the etiology of this
disease, the role of the immune system and the effectiveness
of immunomodulators in treatment of CAP [27].
Thus, high prevalence of HI and CMVI, the possibility
of the persistence of herpesviruses in the human body for
lifetime, their activation in immunosuppression, difficulties
of clinical and laboratory diagnostics, lack of effective thera-
peutic and prophylactic measures serve as a reason for further
complex study of these male infections being of significant
importance to science and practice. The improvement of ther-
apeutic, diagnostic and rehabilitative measures in men with HI
and CMVI has an important medical and social significance.
The etiology and pathogenesis are not the only problem of
chronic prostatitis. Treatment approaches to this disease are
problematic as well. According to some authors, at present,
there are no substantial approaches to treatment of chronic pro-
statitis: therapy should be aimed at eliminating the infectious
agent, normalizing the immune status, regressing inflamma-
tory changes and restoring the function of the prostate [6, 29].
The main principles of treatment should include the following:
the effect on all the chains of the etiology and pathogenesis
of the disease; analysis and consideration of the activity, cate-
gories and extent of the process, application of a complex of
therapeutic measures [34].
Widespread use of non-steroidal anti-inflammatory drugs
by patients with chronic prostatitis is quite justified and patho-
genetically substantiated, with the rectal route of administra-
tion being particularly successful [34, 35]. The effectiveness
of enzyme preparations in chronic prostatitis is highlighted in
national literature.
An innovative approach to treating chronic prostatitis is
the use of α-adrenoblockers. Various drug therapies, prostate
massage, hirudotherapy, physiotherapeutic procedures and
other treatment methods are used to restore blood circulation
in small pelvis and microcirculation in the prostate gland in pa-
tients with chronic prostatitis. In recent years, many research
works concerning the use of preparations obtained from the
prostate of cattle being purified from hormones and proteins
(e.g. raveron, prostaveron, prostatilen) in combination treat-
ment of patients with chronic prostatitis have been published.
According to some experts, it is reasonable to use antisense
drugs in combination therapy for prostatitis to neutralize the
effect of histamine being a mediator of vascular reactions
at the inflammation site. Several authors used to prescribe
diphenhydramine in the form of rectal suppositories for this
purpose [29, 36].
The literature data of the last decade indicate the pres-
ence of immunodeficiency in patients with chronic prostatitis,
and moreover, both inflammatory and local immunity is sup-
pressed. The necessity of mandatory consideration of these
factors in the administration of combination therapy is em-
phasized [36, 37, 38]. Medicinal herbs are used in various
combinations for their diverse effects on the body. Modern
phytotherapists often prefer various herbal combinations [39].
Some authors offer homeopathic remedies for treatment of
patients with chronic prostatitis. To increase the resistance of
human body to infection, a number of authors recommend ad-
ministration of vitamins when treating patients with prostatitis.
Other authors report the effectiveness of zinc in treatment of
patients with chronic prostatitis. Prostate massage has been
used in treatment of chronic prostatitis since the 19th century;
however, there is still no unified view of its effect as compared
to other methods used to treat this widespread disease. In most
cases of chronic prostatitis, it is important to pay attention to
the normalization of the mental status of the patient admin-
istring both medication therapy and rational psychotherapy
[40]. Ukrainian and Russian urologists use a large variety of
physiotherapeutic procedures to treat patients with chronic
prostatitis more often than their foreign collegues; however,
pathogenetic practicability of their application is not well-
substantiated, and their effectiveness requires further study
[36, 41].
A lot of representatives of pharmacological groups are
used for treatment of CPPS. Their diversity is explained by the
lack of a clear understanding of the etiology and pathogenesis
of the disorder, as well as its resistance to treatment and high
frequency of reccurence of pain syndrome.
Thus, modern views toward the development, etiology,
pathogenesis, as well as treatment of chronic prostatitis are
very ambiguous. There is a number of disputable questions
that require further thorough study using the latest techniques.
The provability of viral etiology of chronic CAP remains
actual at the current stage. However, the role of HSV and
CMV as the etiology of CAP in men has not been clearly
proven yet.
Thus, today chronic prostatitis should be considered as a
disease with complex pathogenesis and polymorphic clinical
picture. Its clinical manifestations and the possibility of their
adequate correction will aquire an additional content as soon
as the range of verification methods of this pathology and
introduction of new therapeutic technologies expand.
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